Host immune status and response to hepatitis E virus infection.
about
Hepatitis E Virus Mutations: Functional and Clinical RelevanceHepatitis E virus infection: Epidemiology and treatment implicationsLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsApproved Antiviral Drugs over the Past 50 YearsTherapeutic targets for the treatment of hepatitis E virus infectionUse of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.The development of a recombinant hepatitis E vaccine HEV 239.Activation of CXCL-8 Transcription by Hepatitis E Virus ORF-1 via AP-1.Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment.Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection.Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection.Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infectionThe ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-κB Signaling via TRADD and RIP1.Hepatitis E virus infection in patients with acute non-A, non-B, non-C hepatitis in Central Brazil.Risk factors for hepatitis E virus infection and disease.Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.Detection of viral hepatitis E in clinical liver biopsies.Hepatitis E in post-liver transplantation: is it time to routinely consider it?Production and characterization of a Brazilian candidate antigen for Hepatitis E Virus genotype 3 diagnosis.Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.A cross-sectional study among Polish hunters: seroprevalence of hepatitis E and the analysis of factors contributing to HEV infections.Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.Development and validation of a new serum standard for the measurement of anti-HEV antibodies in animals.Susceptibility of Pigs to Zoonotic Hepatitis E Virus Genotype 3 Isolated from a Wild Boar.New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France.Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection.Acute hepatitis E virus infection causing acute liver failure requiring living-donor liver transplantation in a non-pregnant immunocompetent woman.Public health risks associated with hepatitis E virus (HEV) as a food‐borne pathogenVaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges.Positive regulation of hepatitis E virus replication by microRNA-122.Risk factors for hepatitis E virus seropositivity in Dutch blood donors.
P2860
Q26741356-FDE9999B-5C4B-4549-9EC7-BD3F1E395DB6Q26777044-D175CED9-31D4-4952-831D-732C16EF0DB7Q27013018-35FCC9F6-7271-48B1-A49D-50CF968D5F0AQ27755387-9242BDB7-AD26-41C1-ADC4-CA70FAB5209BQ28084036-0F72E00A-C931-4845-A49A-021CC800FD33Q30249278-4AE6DFF5-1B13-40CB-83AF-C69CE7FB86D7Q33433261-1B1D5888-7DDB-4E6A-AEC0-56D5738AEBDDQ34464464-0709E28A-977F-47BC-8733-0D210B640121Q35620921-D10700F0-AC38-4A57-A201-541296168338Q35865394-805A6E3C-A826-4BCB-B44D-EA7B01548CB2Q35887653-AEF0B123-FE30-41B2-BB0B-339DB31726A3Q35926258-E278688E-9F29-47C7-930C-FD40C33C868EQ36609717-CA602D95-9078-493F-8D7F-F26F568A8C3CQ36811948-D58AC852-4AE6-45FF-8C21-CEBEBBF79F61Q36828854-6C91E9D1-B969-45B9-9F55-DD267EEBF4D8Q36887931-792AE9D6-C6E2-489C-B725-6D50854CDCDEQ36980637-1E2CE9B5-9416-44D6-A5FC-88E49516A3A3Q37444521-6146493F-E436-4F44-AEEB-F0149968F7F5Q38268414-B019828E-A75C-432D-87D5-9DD7959AB48FQ38538122-9F9A320B-2F88-47F0-954A-61C7190E8C0DQ38764392-D736B33F-B427-4402-AB10-A588113CC71FQ38854364-E2C1B659-7D15-48F4-A610-5A6F327B74F5Q40035451-1204660B-E5A5-49FE-8689-0DD56E901112Q40082002-9694E815-0F42-4B09-A1E7-8D01660207CEQ40095037-E4DEB12A-1B69-4E34-8076-2F0C828264E7Q40248978-A16F5CCE-5866-448C-9F96-94227A841AC8Q40589840-1E6DE914-6B46-4AC5-A5B8-915BB7626517Q40593532-75E2DC87-8B8B-4D4B-9321-64E546EBF48FQ40750656-343C0F77-05BF-4557-84E9-DF115AA3DF97Q43168143-3B6C015F-4BEF-4BA0-AB1C-B8AB5343746AQ45329959-38BF200F-235A-4E20-89CB-0674D1632C9EQ47159881-4895EF97-258B-477F-AE44-01F49D610F31Q51784137-C9E13376-50C7-4912-96C4-09CCEB15E418Q52355426-9B5B5970-17AC-4A86-B07F-91C0714DCAEFQ54236240-E991E7DC-833B-4A6B-A324-9C13865F3279
P2860
Host immune status and response to hepatitis E virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host immune status and response to hepatitis E virus infection.
@en
Host immune status and response to hepatitis E virus infection.
@nl
type
label
Host immune status and response to hepatitis E virus infection.
@en
Host immune status and response to hepatitis E virus infection.
@nl
prefLabel
Host immune status and response to hepatitis E virus infection.
@en
Host immune status and response to hepatitis E virus infection.
@nl
P2860
P356
P1476
Host immune status and response to hepatitis E virus infection
@en
P2093
Alain B Labrique
Kenrad E Nelson
P2860
P304
P356
10.1128/CMR.00062-13
P407
P50
P577
2014-01-01T00:00:00Z